<DOC>
	<DOCNO>NCT00366522</DOCNO>
	<brief_summary>To evaluate safety tolerability single dose LXR-623 healthy subject .</brief_summary>
	<brief_title>Study Evaluating LXR-623 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Inclusion : Healthy , men woman , age 1950 year Exlcusion : Use investigational prescription drug within 30 day study start Any clinically imprtant medical disease abnormal laboratory test result</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Safety</keyword>
	<keyword>Healthy</keyword>
	<keyword>healthy subject</keyword>
</DOC>